MMP13 can be a useful differentiating marker between squamous cell carcinoma and benign hyperkeratotic lesions in recessive dystrophic epidermolysis bullosa

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|172|3|769-773

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.172, Iss.3, 2015-03, pp. : 769-773

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Criteria for Differentiating between Recessive and Dominant Forms of Dystrophic Epidermolysis Bullosa, Elaborated from an Analysis of 119 Cases

By  

THE JOURNAL OF DERMATOLOGY, Vol. 20, Iss. 5, 1993-05 ,pp. : 269-275

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa

By  

Recent Patents on Nanomedicine, Vol. 4, Iss. 1, 2014-06 ,pp. : 15-24

Bentham Science Publishers

Access to resources Recommend Favorite

Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 6, 2015-06 ,pp. : 1680-1682

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pseudosyndactyly – an inflammatory and fibrotic wound healing disorder in recessive dystrophic epidermolysis bullosa

By  

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 13, Iss. 12, 2015-12 ,pp. : 1257-1266

John Wiley & Sons Inc

Access to resources Recommend Favorite

Two Autopsy Cases of Recessive Dystrophic Epidermolysis Bullosa and an Analysis of Recorded Cases in Japan

By  

THE JOURNAL OF DERMATOLOGY, Vol. 13, Iss. 4, 1986-08 ,pp. : 307-309

John Wiley & Sons Inc

Access to resources Recommend Favorite